These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27215208)

  • 21. Respiratory allergy caused by house dust mites: What do we really know?
    Calderón MA; Linneberg A; Kleine-Tebbe J; De Blay F; Hernandez Fernandez de Rojas D; Virchow JC; Demoly P
    J Allergy Clin Immunol; 2015 Jul; 136(1):38-48. PubMed ID: 25457152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Intervention Improves Clinical Responses to House Dust Mite Immunotherapy in Allergic Rhinitis Patients.
    Qi S; Chen H; Huang N; Li W; Liu G; Wang Y; Hu L; Wang X; Zhang W; Zhu R
    Int Arch Allergy Immunol; 2016; 171(3-4):234-240. PubMed ID: 28049194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
    Bozek A; Ignasiak B; Filipowska B; Jarzab J
    Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC; Demoly P; Worm M; Fokkens WJ; Carrillo T; Tabar AI; Nguyen H; Montagut A; Zeldin RK
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of circulating house dust mite-specific IL-4- and IL-13-secreting T cells correlates with rhinitis severity in asthmatic children and varies with the seasons.
    Michaud B; Gouvis-Echraghi R; Candon S; Couderc R; Jais JP; Bach JF; Chatenoud L; Just J
    Clin Exp Allergy; 2014 Feb; 44(2):222-30. PubMed ID: 24447084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.
    Demoly P; Okamoto Y; Yang WH; Devillier P; Bergmann KC
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1141-1151. PubMed ID: 27632814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The correlation between the seasonal variation of house dust mite allergens exposure level in household and the level of asthma control in asthmatic children].
    Xiang L; Fu Y; Wang J; Wang Q
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):177-83. PubMed ID: 24824386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seasonal trends in house dust mite allergen in children's beds over a 7-year period.
    Crisafulli D; Almqvist C; Marks G; Tovey E
    Allergy; 2007 Dec; 62(12):1394-400. PubMed ID: 17983374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial.
    Devillier P; Fadel R; de Beaumont O
    Allergy; 2016 Feb; 71(2):249-57. PubMed ID: 26465232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
    Marogna M; Spadolini I; Massolo A
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of local allergic rhinitis sensitized to house dust mites in Asia.
    Kim SJ; Moon JW; Cho Y; Lee HM
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2413-2420. PubMed ID: 38147114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High sensitization to house-dust mites in patients with allergic rhinitis in the eastern Black Sea region of Turkey: A retrospective study.
    Coskun ZO; Erdivanlı OC; Kazıkdas KÇ; Terzi S; Sahin U; Ozgur A; Demirci M; Dursun E; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):351-355. PubMed ID: 27465310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the minimally important difference in a nasal symptom score in house dust mite allergy.
    Devillier P; Brüning H; Bergmann KC
    Allergy; 2019 Nov; 74(11):2191-2198. PubMed ID: 31124151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cluster analysis of indoor environmental factors associated with symptoms of mite allergy.
    Virot E; Godet J; Khayath N; Ott M; Dazy A; de Blay F
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):280-283. PubMed ID: 31175929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pattern of indoor and outdoor respiratory allergens in asthmatic adult patients in a humid and desert newly developed country.
    Sattar HA; Mobayed H; al-Mohammed AA; Ibrahim AS; Jufairi AA; Balamurugan P; Mary VP; Bener A
    Eur Ann Allergy Clin Immunol; 2003 Oct; 35(8):300-5. PubMed ID: 14653049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.
    Mosbech H; Deckelmann R; de Blay F; Pastorello EA; Trebas-Pietras E; Andres LP; Malcus I; Ljørring C; Canonica GW
    J Allergy Clin Immunol; 2014 Sep; 134(3):568-575.e7. PubMed ID: 24797423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.